Mondrian Investment Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $189M | Sell |
1,473,945
-107,582
| -7% | -$12.6M | 2.92% | 11 |
|
|
2026
Q1 | $190M | Sell |
1,581,527
-28,705
| -2% | -$3.31M | 2.85% | 11 |
|
|
2025
Q4 | $169M | Sell |
1,610,232
-38,085
| -2% | -$3.58M | 2.8% | 12 |
|
|
2025
Q3 | $138M | Buy |
+1,648,317
| New | +$136M | 2.31% | 18 |
|
|
2025
Q1 | $129M | Buy |
1,433,392
+278,925
| +24% | +$26M | 2.2% | 16 |
|
|
2024
Q4 | $114M | Buy |
+1,154,467
| New | +$119M | 1.89% | 27 |
|
|
2020
Q3 | – | Sell |
-472
| Closed | -$35K | – | 111 |
|
|
2020
Q2 | $35K | Hold |
472
| – | – | ﹤0.01% | 104 |
|
|
2020
Q1 | $35K | Sell |
472
-86
| -15% | -$6.76K | ﹤0.01% | 96 |
|
|
2019
Q4 | $48K | Hold |
558
| – | – | ﹤0.01% | 101 |
|
|
2019
Q3 | $45K | Hold |
558
| – | – | ﹤0.01% | 103 |
|
|
2019
Q2 | $45K | Hold |
558
| – | – | ﹤0.01% | 101 |
|
|
2019
Q1 | $44K | Hold |
558
| – | – | ﹤0.01% | 102 |
|
|
2018
Q4 | $41K | Hold |
558
| – | – | ﹤0.01% | 98 |
|
|
2018
Q3 | $38K | Hold |
558
| – | – | ﹤0.01% | 104 |
|
|
2018
Q2 | $32K | Sell |
558
-550
| -50% | -$31K | ﹤0.01% | 110 |
|
|
2018
Q1 | $62K | Hold |
1,108
| – | – | ﹤0.01% | 112 |
|
|
2017
Q4 | $59K | Hold |
1,108
| – | – | ﹤0.01% | 116 |
|
|
2017
Q3 | $68K | Hold |
1,108
| – | – | ﹤0.01% | 102 |
|
|
2017
Q2 | $68K | Hold |
1,108
| – | – | ﹤0.01% | 102 |
|
|
2017
Q1 | $67K | Hold |
1,108
| – | – | ﹤0.01% | 106 |
|
|
2016
Q4 | $62K | Hold |
1,108
| – | – | ﹤0.01% | 105 |
|
|
2016
Q3 | $66K | Hold |
1,108
| – | – | ﹤0.01% | 108 |
|
|
2016
Q2 | $61K | Hold |
1,108
| – | – | ﹤0.01% | 110 |
|
|
2016
Q1 | $56K | Hold |
1,108
| – | – | ﹤0.01% | 118 |
|
|
2015
Q4 | $56K | Hold |
1,108
| – | – | ﹤0.01% | 78 |
|
|
2015
Q3 | $52K | Hold |
1,108
| – | – | ﹤0.01% | 78 |
|
|
2015
Q2 | $60K | Sell |
1,108
-765,189
| -100% | -$42.9M | ﹤0.01% | 71 |
|
|
2015
Q1 | $42M | Sell |
766,297
-18,766
| -2% | -$1.06M | 0.69% | 38 |
|
|
2014
Q4 | $42.5M | Sell |
785,063
-229,673
| -23% | -$12.8M | 0.69% | 37 |
|
|
2014
Q3 | $57.4M | Sell |
1,014,736
-7,860
| -0.8% | -$441K | 0.8% | 35 |
|
|
2014
Q2 | $56.4M | Buy |
1,022,596
+3,458
| +0.3% | +$189K | 0.79% | 36 |
|
|
2014
Q1 | $55.2M | Sell |
1,019,138
-486,272
| -32% | -$25.2M | 0.81% | 36 |
|
|
2013
Q4 | $71.9M | Sell |
1,505,410
-62,670
| -4% | -$2.86M | 1.01% | 30 |
|
|
2013
Q3 | $71.2M | Sell |
1,568,080
-35,842
| -2% | -$1.64M | 1.05% | 27 |
|
|
2013
Q2 | $71.1M | Buy |
+1,603,922
| New | +$71.6M | 1.08% | 27 |
|
Other funds holding MRK
Mondrian Investment Partners's MRK Position: Q2 2026 in Review
Mondrian Investment Partners reduced its Merck (MRK) stake by 6.8% in Q2 2026, selling an estimated $12.6M and leaving 1,473,945 shares worth $189M. The position accounts for 2.92% of the portfolio, ranked #11.
Mondrian Investment Partners first reported a position in MRK in Q2 2013 and has held it in 35 quarters since. The position peaked at $190M in Q1 2026. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Mondrian Investment Partners held 1,473,945 shares of Merck worth $189M as of Q2 2026.
- Mondrian Investment Partners sold 107,582 Merck shares in Q2 2026, an estimated $12.6M.
- Merck made up 2.92% of Mondrian Investment Partners's portfolio in Q2 2026, its #11 holding.
- Mondrian Investment Partners first reported a position in Merck in Q2 2013 and has held it in 35 quarters since.
- Mondrian Investment Partners's Merck position peaked at $190M in Q1 2026.
- 3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Mondrian Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.